Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CDD3505 (4-nitro-1-trityl-1H-imidazole) increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 38.00 | |
5 mg | In stock | $ 89.00 | |
10 mg | In stock | $ 155.00 | |
25 mg | In stock | $ 282.00 | |
50 mg | In stock | $ 419.00 | |
100 mg | In stock | $ 597.00 | |
500 mg | In stock | $ 1,280.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 98.00 |
Description | CDD3505 (4-nitro-1-trityl-1H-imidazole) increases high-density lipoprotein cholesterol by targeting hepatic CYP3A. |
Synonyms | 4-nitro-1-trityl-1H-imidazole |
Molecular Weight | 355.39 |
Formula | C22H17N3O2 |
CAS No. | 173865-33-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5 mg/mL (14.07 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CDD3505 173865-33-3 Metabolism P450 Cytochrome P450 CYPs inhibit 4-nitro-1-trityl-1H-imidazole Inhibitor CDD 3505 CDD-3505 inhibitor